I am Director of Early Phase Clinical Trials Unit in Imperial College, and have clinical expertise in the treatment of patients with breast cancer.
I qualified Medicine in Queen’s University Belfast, after completion of junior medical training Ochose to specialise in medical oncology. Following initial registrar training, I studied for a PhD in translational molecular imaging in Imperial College London, funded by a Westminster Medical School Oncology Trustee’s fellowship.
My research focused on the use of novel PET radiotracers for studying cancer biology, treatment response, and drug resistance. My work has been published in Cancer Research, Clinical Cancer Research, the Journal of Nuclear Medicine, and the European Journal of Molecular Imaging and Nuclear Medicine, and I present my work regularly in international conferences.
I was awarded a prestigious NIHR/MRC clinician scientist fellowship in 2010, and am leading a new project funded by the MRC to develop a new imaging probe in breast cancer.
I am a visiting Professor at the University of Cardiff and my research has been recognised by the American Association of Cancer Research (Young Investigator Award), American Society of Clinical Oncology (Merit Award), British Cancer Research Meeting (Translational Research Award), and the Association of Cancer Physicians (McElwain Prize).